Semaglutide

Sort by

Trp(tBu)-Semagltuide

  • CAT NUMBER DCTI-D-373
  • CAS NUMBER NA
  • MOLECULAR FORMULA C191H299N45O59
  • MOLECULAR WEIGHT 4169.75

U6 Semaglutide

  • CAT NUMBER DCTI-D-463
  • CAS NUMBER NA
  • MOLECULAR FORMULA C27H47N5O14
  • MOLECULAR WEIGHT 665.69

α-Glu(side chain)-Semaglutide

  • CAT NUMBER DCTI-D-348
  • CAS NUMBER NA
  • MOLECULAR FORMULA C187H291N45O59
  • MOLECULAR WEIGHT 4113.64 Da

γ-Glu(15)-Semaglutide

  • CAT NUMBER DCTI-D-400
  • CAS NUMBER NA
  • MOLECULAR FORMULA C187H291N45O59
  • MOLECULAR WEIGHT 4113.64

γ-Glu(3)-Semaglutide

  • CAT NUMBER DCTI-D-382
  • CAS NUMBER NA
  • MOLECULAR FORMULA C187H291N45O59
  • MOLECULAR WEIGHT 4113.64
LOAD MORE
You're viewed all 41 products
References
FAQ's

Frequently Asked Questions

The process-related impurities of Semaglutide include peptide impurities like Endo-Gly(4), Endo-Gly(16), Endo-Gly(31),  Endo-Ala(18), D-Ser(11), D-Ser(12), and inorganic impurities, which can affect the drug’s safety, quality, and efficacy.

Semaglutide impurities can affect the shelf life of the drug product due to the degradation of the active pharmaceutical ingredient or reaction with other components during formulation.

Liquid chromatography-mass spectrometry (LC-MS), infrared (IR) spectroscopy, and high-performance liquid chromatography (HPLC) are some of the analytical methods used in the identification & characterization processes of Semaglutide impurities.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart